Chen Chen

Chen Chen

Auto-generated profile, based on publicly available information

Chen Chen

College of Basic Medical Sciences, Shanxi University of Traditional Chinese Medicine, Jinzhong, PR China

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2019 in Aging
Verified
Journal Article
Open access
MHMengying He
Mengying He
JWJin Wang
Jin Wang
ZYZhongwei Yin
Zhongwei Yin
YZYanru Zhao
Yanru Zhao
HHHuiying Hou
Huiying Hou
CCChen Chen
Chen Chen
Multiple studies indicate that microRNAs (miRNAs) are involved in diabetes. However, the roles of miRNA in the target organ damages in diabetes remain unclear. This study investigated the functions of miR-320a in diabetic nephropathy (DN). In this study, db/db mice were used to observe the changes in podocytes and their function in vivo, as well as in cultured mouse podocyte cells (MPC5) exposed to high glucose in vitro. To further explore the role of miR-320a in DN, recombinant adeno-associated viral particle was administered intravenously to manipulate the expression of miR-320a in db/db mice. Overexpression of miR-320a markedly promoted podocyte loss and dysfunction in DN, including mesangial expansion and increased levels of proteinuria, serum creatinine and urea nitrogen. Furthermore, MafB was identified as a direct target of miR-320a through AGO2 co-immunoprecipitation, luciferase reporter assay, and Western blotting. Moreover, re-expression of MafB rescued miR-320a-induced podocyte loss and dysfunction by upregulating the expressions of Nephrin and glutathione peroxidase 3 (Gpx3). Our data indicated that miR-320a aggravated renal disfunction in DN by targeting MafB and downregulating Nephrin and Gpx3 in podocytes, which suggested that miR-320a could be a potential therapeutic target of diabetic nephropathy.

5 June 2015 in Obesity
Verified
Journal Article
Open access
PDF file
SZShasha Zhang
Shasha Zhang
GCGuangzhi Chen
Guangzhi Chen
Ning LiNing Li
Ning Li
MDMeiyan Dai
Meiyan Dai
CCChen Chen
Chen Chen
XXXizhen Xu
Xizhen Xu
Objective The study aims to investigate the effect of cytochrome P450 2J2 (CYP2J2) overexpression on hyperlipidemia in mice and further to explore its effect on fatty acid oxidation in vivo and in vitro. Methods The effects and mechanisms of endothelial‐specific CYP2J2 transgene (Tie2‐CYP2J2‐Tr) on lipid and fatty acid metabolism were investigated in high‐fat diet (HFD) ‐treated mice. HepG2, LO2 cells, and HUVECs were exposed to 0.4 mM free fatty acid (FFA) for 24 h and used as a model to investigate the roles of CYP2J2 overexpression and epoxyeicosatrienoic acids (EETs) on fatty acid β‐oxidation in vitro. Results Tie2‐CYP2J2‐Tr mice had significantly lower plasma and liver triglycerides, lower liver cholesterol and fatty acids, and reduced HFD‐induced lipid accumulation. CYP2J2 overexpression resulted in activation of the hepatic and endothelial AMPKα, increased ACC phosphorylation, and increased expression of CPT‐1 and PPARα, which were all reduced by HFD treatment. In FFA‐treated HepG2, LO2, and HUVECs, both CYP2J2 overexpression and EETs significantly decreased lipid accumulation and increased fatty acid oxidation via activating the AMPK and PPARα pathways. Conclusions Endothelial‐specific CYP2J2 overexpression alleviates HFD‐induced hyperlipidemia in vivo. CYP2J2 ameliorates FFA‐induced dyslipidemia via increased fatty acid oxidation mediated by the AMPK and PPARα pathways.

9 May 2024 in Autoimmunity
Verified
Journal Article
Open access
YHYiwen Hou
Yiwen Hou
CCChen Chen
Chen Chen
ZLZhurong Li
Zhurong Li
JWJiawen Wu
Jiawen Wu
SLSixue Lyu
Sixue Lyu
THTiezheng Hou
Tiezheng Hou
Yinchenhao Decoction (YCHD) is a classic prescription in traditional Chinese medicine (TCM). It appears to play an important role in anti-inflammation and autoimmunity protection. As one of the key active ingredients in YCHD, quercetin is a novel anti-inflammatory metabolite that exerts protective effects in many autoimmune diseases. However, its role in autoimmune hepatitis (AIH)-related hepatic injury has not been studied. The aim of this study was to reveal the hepatocyte protective mechanism of quercetin. In this study, we used Concanavalin A (Con A) to establish an in vitro hepatocyte injury-associated AIH model. Brl3a hepatocyte injury was induced by the supernatant of J774A.1 cells treated with Con A. We found that quercetin mitigated Con A-induced via macrophage-mediated Brl3a hepatocyte injury. Quercetin administration reduced the levels of alanine transaminase (ALT) and aspartate transaminase (AST) in the supernatant of Con A-treated Brl3a cells and attenuated the infiltration of J774A.1 macrophages induced by Con A. Moreover, quercetin effectively inhibited the expression of proinflammatory cytokines including interleukin-1β (IL-1β) by Con A. Furthermore, quercetin decreased hepatocyte apoptosis and ferroptosis levels in the macrophage-induced hepatocyte injury model. In conclusion, our study indicates that quercetin alleviates macrophage-induced hepatocyte damage by reducing the inflammatory response, apoptosis and ferroptosis. Our work suggests that quercetin might be a potential therapeutic strategy for AIH.

1 September 2020 in Virus Research
Verified
Journal Article
Closed access
CCChen Chen
Chen Chen
YXYong Xia
Yong Xia
SZShuirong Zhu
Shuirong Zhu
FXFang Xu
Fang Xu
YSYisheng Sun
Yisheng Sun
PYPing-Ping Yao
Ping-Ping Yao

9 July 2011 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
BZBo Zhu
Bo Zhu
RPRi-He Peng
Ri-He Peng
Ai-Sheng XiongAi-Sheng Xiong
Ai-Sheng Xiong
XFXiaoyan Fu
Xiaoyan Fu
WZWei Zhao
Wei Zhao
QYQuan-Hong Yao
Quan-Hong Yao

23 May 2017 in Clinical and Experimental Hypertension
Verified
Journal Article
Closed access
XCXiao-Jing Chen
Xiao-Jing Chen
CCChen Chen
Chen Chen
YLYu-Jia Liang
Yu-Jia Liang
XGXi-Lian Gao
Xi-Lian Gao
JJJing Jiang
Jing Jiang
ZZZhi Zeng
Zhi Zeng
Suboptimal blood pressure (BP) control is commonly observed in patients receiving antihypertensive agents, but the relationship between uncontrolled BP and left atrial (LA) impairment remains unknown. This study enrolled 279 hypertensive patients who had been medicated, as well as 85 matched normal controls. The BP of systolic 140/90 mmHg appeared an independent risk factor associated with the abnormal SEa (odds ratio, 2.957; interval of confidence, 1.614-5.415; p = 0.001). Suboptimal BP control status in hypertensive patients is related to a further reduction of LA myocardial function assessed by the novel 2DSTI free strain, and suboptimal BP might be regarded as a composite risk factor and therefore a simplified treatment target. However, the prognostic value of LA free strain in patients with inability to achieve the BP target needs to be evaluated in future prospective studies.